Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process ; volume:15 ; number:1 ; day:22 ; month:7 ; year:2015 ; pages:1-7 ; date:12.2015
BMC psychiatry ; 15, Heft 1 (22.7.2015), 1-7, 12.2015
- Urheber
-
Kadra, Giouliana
- Beteiligte Personen und Organisationen
-
Stewart, Robert
Shetty, Hitesh
Jackson, Richard G.
Greenwood, Mark A.
Roberts, Angus
Chang, Chin-Kuo
MacCabe, James H.
Hayes, Richard D.
SpringerLink (Online service)
- DOI
-
10.1186/s12888-015-0557-z
- URN
-
urn:nbn:de:1111-2016110919669
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kadra, Giouliana
- Stewart, Robert
- Shetty, Hitesh
- Jackson, Richard G.
- Greenwood, Mark A.
- Roberts, Angus
- Chang, Chin-Kuo
- MacCabe, James H.
- Hayes, Richard D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic polypharmacy prescribing and risk of hospital readmission
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Antipsychotic polypharmacy in a regional health service: a population-based study
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study
A case of malignant hyperthermia that was difficult to be differentiated from oral antipsychotic polypharmacy-associated neuroleptic malignant syndrome
EXTRACTING AND EVALUATING CLUSTERS IN DINSAR DEFORMATION DATA ON SINGLE BUILDINGS
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic polypharmacy prescribing and risk of hospital readmission
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Antipsychotic polypharmacy in a regional health service: a population-based study
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study
A case of malignant hyperthermia that was difficult to be differentiated from oral antipsychotic polypharmacy-associated neuroleptic malignant syndrome
EXTRACTING AND EVALUATING CLUSTERS IN DINSAR DEFORMATION DATA ON SINGLE BUILDINGS
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic polypharmacy prescribing and risk of hospital readmission
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Antipsychotic polypharmacy in a regional health service: a population-based study
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study
A case of malignant hyperthermia that was difficult to be differentiated from oral antipsychotic polypharmacy-associated neuroleptic malignant syndrome